LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards
as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
The firm and its partners were also shortlisted for:* Inter-Partes Review Firm of the Year* Post Grant Proceedings Attorney of the Year: Naveen Modi* General Patent Litigator of the Year – New York: Bruce Wexler
